モデル分子スイッチに対するアロステリックな混乱のシステムレベルの影響
Tina Perica1,2,3, Christopher J P Mathy1,2,4, Jiewei Xu2,5,6
1Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.
Nature
|October 14, 2021
まとめ
Gsp1 (RAN) のような分子スイッチの機能的特異性は,細胞プロセスがタンパク質にどのように反応するかから生じる.
科学分野:
- 分子生物学
- 生物化学
- セルラー信号
背景:
- 分子スイッチタンパク質は信号伝達に不可欠であり,複雑な相互作用ネットワーク内で動作します.
- 機能的特異性を理解することは,異なる生物学的プロセスで共通の調節物質が共有されている場合に鍵となる.
研究 の 目的:
- Saccharomyces cerevisiaeの小さなGTPaseスイッチタンパク質Gsp1 (RAN) の機能的特異性がどのように達成されるかを調査する.
- Gsp1 (RAN) 相互作用インターフェースの乱れと細胞効果の関係を決定する.
主な方法:
- Gsp1 (RAN) タンパク質の相互作用界面で55の標的点変異を生成した.
- 細胞の影響を評価するために定量的な遺伝的および物理的な相互作用マッピングを使用した.
- GTPaseのスイッチサイクルの動力学に対する変異の生体物理的効果を分析した.
主要な成果:
- Gsp1 (RAN) インターフェースの変異は,標的型インターフェースではなく,運動パラメータへの影響によってグループ化され,広範な細胞効果を持っていた.
- 変異はGTPaseのスイッチサイクルをアロステリックに調整することが示された.
- Gsp1 (RAN) スイッチサイクル運動に対する生物学的プロセスの微分感受性は,機能的特異性の基礎となっている.
結論:
- プロテイン・パートナー結合またはディスタル・ポストトランスレーション・モディフィケーションは,GTPaseスイッチングのアロステリック・レギュレーターとして作用する.
- 生物学的スイッチを制御する一般的なメカニズムを示唆しています
- 統合的なプラットフォームが開発され,病気の変異を理解するのに役立つ分子乱射効果を定量化しました.
関連する概念動画
Cooperative Allosteric Transitions
8.2K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.2K
Allosteric Regulation
61.1K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
61.1K
Allosteric Proteins-ATCase
6.0K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.0K
Ligand Binding and Linkage
5.1K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.1K
The Two-State Receptor Model
2.6K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.6K
Regulation of Metabolism
10.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.4K


